USDMF Available For Eslicarbazepine Acetate


Alkem Activa is pleased to announce yet another achievement in their API journey with successful USDMF filing for Eslicarbazepine Acetate API.
The successful USDMF filing underscores our dedication to regulatory compliance, product excellence and meeting ever increasing needs of the pharmaceutical industry.
Contact us for your API requirements and let’s create success stories together.
To know more about our API’s visit to our website www.alkemactiva.com or write to us at api@alkemactiva.com and we will be pleased to support your requirements.
One Brand, Countless health stories.